Terms: = Gastric cancer AND PR, PGR, progesterone receptor
888 results:
1. ApoA-I and ApoB levels, and ApoB-to-ApoA-I ratio as candidate pre-treatment biomarkers of pathomorphological response to neoadjuvant therapy in gastric and esophago-gastric junction adenocarcinoma.
Nurczyk K; Nowak N; Orczykowski T; Bojar P; Duma D; Gieroba R; Wallner G; Skoczylas T
Pol Przegl Chir; 2023 Sep; 96(2):44-49. PubMed ID: 38629280
[TBL] [Abstract] [Full Text] [Related]
2. Clinical evidence for efficacy of pembrolizumab in MSI-H and TMB-H advanced solid tumor: results from three cancer centers in China.
Yan H; Song L; Li Y; Xu Q; Guo W; Lin S; Jiang W; Wang Z; Deng L; Huang Z; Qin H; Zhang X; Tong F; Zhang R; Liu Z; Zhang L; Yu J; Dong X; Gong Q; Deng J; Chen X; Wang J; Zhang G; Yang N; Zhang Y; Zeng L
Cancer Immunol Immunother; 2024 Mar; 73(4):74. PubMed ID: 38451314
[TBL] [Abstract] [Full Text] [Related]
3. Efficacy of ramucirumab combination chemotherapy as second-line treatment in patients with advanced adenocarcinoma of the stomach or gastroesophageal junction after exposure to checkpoint inhibitors and chemotherapy as first-line therapy.
Masetti M; Al-Batran SE; Goetze TO; Thuss-Patience P; Knorrenschild JR; Goekkurt E; Folprecht G; Ettrich TJ; Lindig U; Luley KB; Pink D; Dechow T; Sookthai D; Junge S; Loose M; Pauligk C; Lorenzen S
Int J Cancer; 2024 Jun; 154(12):2142-2150. PubMed ID: 38447003
[TBL] [Abstract] [Full Text] [Related]
4. [A Case of Lymph Nodes Metastases of gastric Neuroendocrine Carcinoma Treated with Nivolumab and Showing Complete Response].
Wada N; Takachi K; Shirosaki Y; Fujiwara M; Fukuda N; Matsuura Y; Munakata K; Takiuchi D; Hama N; Ota H
Gan To Kagaku Ryoho; 2023 Dec; 50(13):1546-1547. PubMed ID: 38303336
[TBL] [Abstract] [Full Text] [Related]
5. [A Case of Postoperative Recurrence of Liver Metastasis after Gastrectomy for gastric cancer-No Recurrence for Five Years after Twice Liver Resections].
Fukumoto S; Yamamoto Y; Yanagawa S; Takaya M; Amioka J; Kaneko Y; Watanabe A; Nishina M; Mashima H; Sumi Y; Yamaki M; Kurayoshi M; Oshita A; Nakahara M; Noriyuki T
Gan To Kagaku Ryoho; 2023 Dec; 50(13):1895-1896. PubMed ID: 38303244
[TBL] [Abstract] [Full Text] [Related]
6. [A Case of HER2-Positive Unresectable Advanced gastric cancer Showing Long-Term Complete Response Treated by Only Chemotherapy].
Shirasaki Y; Wada N; Takachi K; Fujiwara M; Fukuda N; Matsuura Y; Munakata K; Takiuchi D; Hama N; Ota H
Gan To Kagaku Ryoho; 2023 Dec; 50(13):1887-1888. PubMed ID: 38303241
[TBL] [Abstract] [Full Text] [Related]
7. [A Case of Unresectable Advanced Lower Esophageal Adenocarcinoma That Achieved Pathological Complete Response after Conversion Surgery following Nivolumab plus SOX Therapy].
Yamamichi K; Kotsuka M; Yoshida T; Hishikawa H; Mukaide H; Tokuhara K; Inoue K; Sekimoto M
Gan To Kagaku Ryoho; 2023 Dec; 50(13):1765-1767. PubMed ID: 38303200
[TBL] [Abstract] [Full Text] [Related]
8. [A Case of Recurrent gastric cancer with Long-Term Control via Two Resections and Multidisciplinary Treatment Including Nivolumab].
Bungo M; Takeno A; Hirao M; Hamakawa T; Yamamoto M; Matsui Y; Tokuyama S; Toshiyama R; Kawai K; Takahashi Y; Sakai K; Doi T; Goto K; Kato T; Takami K
Gan To Kagaku Ryoho; 2023 Dec; 50(13):1715-1717. PubMed ID: 38303183
[TBL] [Abstract] [Full Text] [Related]
9. [Conversion Surgery Performed after SOX plus Nivolumab Therapy for Advanced gastric cancer with Para-Aortic Lymph Node Metastasis].
Okuda T; Odagiri K; Yanagimoto Y; Yamashita M; Takeyama H; Suzuki Y; Ikenaga M; Kawase T; Shimizu J; Imamura H; Dono K
Gan To Kagaku Ryoho; 2023 Dec; 50(13):1671-1673. PubMed ID: 38303168
[TBL] [Abstract] [Full Text] [Related]
10. [A Case of Long-Term Survival without Recurrence after Completion of Immunotherapy Due to Response of Third- Line Nivolumab for Liver Metastasis Recurrence of Esophagogastric Junction cancer].
Ryuzaki T; Sentsui T; Amagai H; Sasagawa S; Kobayashi S; Tsukamoto S; Koide Y; Matsubara H
Gan To Kagaku Ryoho; 2023 Oct; 50(10):1126-1129. PubMed ID: 38035852
[TBL] [Abstract] [Full Text] [Related]
11. Analysis of gastrin-17 and its related influencing factors in physical examination results.
Zeng J; Shen Y; Xu S; Yang R
Immun Inflamm Dis; 2023 Oct; 11(10):e993. PubMed ID: 37904688
[TBL] [Abstract] [Full Text] [Related]
12. Concurrent clinical and pathological response predicts favorable prognosis of patients with gastric cancer after neoadjuvant therapy: a real-world study.
Sun C; Niu P; Zhang X; Zhao L; Wang W; Luan X; Han X; Chen Y; Zhao D
BMC Cancer; 2023 Oct; 23(1):996. PubMed ID: 37853387
[TBL] [Abstract] [Full Text] [Related]
13. cancer and Atrial Fibrillation Comorbidities Among 25 Million Citizens in Shanghai, China: Medical Insurance Database Study.
Chen M; Li C; Zhang J; Cui X; Tian W; Liao P; Wang Q; Sun J; Luo L; Wu H; Li YG
JMIR Public Health Surveill; 2023 Oct; 9():e40149. PubMed ID: 37847541
[TBL] [Abstract] [Full Text] [Related]
14. Patterns of Recurrence After Poor Response to Neoadjuvant Chemotherapy in gastric cancer and the Role for Adjuvant Radiation.
Hui C; Ewongwo A; Lau B; Fisher G; Delitto D; Poultsides G; Ho QA; Rahimy E; Pollom E; Chang DT; Vitzthum LK
Ann Surg Oncol; 2024 Jan; 31(1):413-420. PubMed ID: 37755563
[TBL] [Abstract] [Full Text] [Related]
15. Perspectives for immunotherapy of EBV-associated GLELC: A relatively "hot" tumor microenvironment.
Lei Y; Cao P; Zheng X; Wei J; Cheng M; Liu M
Cancer Med; 2023 Oct; 12(19):19838-19849. PubMed ID: 37732493
[TBL] [Abstract] [Full Text] [Related]
16. Application of serum gastric function markers and digestive tumor indices to the diagnosis of early gastric cancer and precancerous lesions.
Yanan Z; Juan W; Jun W; Xin M; Kejian W; Fangyu W
Saudi Med J; 2023 Aug; 44(8):795-800. PubMed ID: 37582570
[TBL] [Abstract] [Full Text] [Related]
17. Stent Graft of Pseudoaneurysm Rupture After Subtotal Stomach-preserving Pancreaticoduodenectomy.
Kimura K; Minagawa R; Yamaoka T; Izumi T; Takahashi YU; Nakanishi M; Tokunaga T; Matsuda D; Honma K; Nagata S; Minami K; Nishizaki T
Anticancer Res; 2023 Aug; 43(8):3639-3645. PubMed ID: 37500164
[TBL] [Abstract] [Full Text] [Related]
18. Immunotherapy Efficacy-related Risk Classifier Differentiate Prognostic Characteristics of gastric cancer-A Large-scale Retrospective Study.
Huo J; Fan X; Sun W; Sun P
J Immunother; 2023 Oct; 46(8):323-332. PubMed ID: 37469271
[TBL] [Abstract] [Full Text] [Related]
19. Noninvasive imaging evaluation of peritoneal recurrence and chemotherapy benefit in gastric cancer after gastrectomy: a multicenter study.
Sun Z; Wang W; Huang W; Zhang T; Chen C; Yuan Q; Chen Y; Zhou K; Han Z; Feng H; Chen H; Liang X; Hu Y; Yu J; Liu H; Yu L; Xu Y; Li G; Jiang Y
Int J Surg; 2023 Jul; 109(7):2010-2024. PubMed ID: 37300884
[TBL] [Abstract] [Full Text] [Related]
20. Calcium electroporation in cutaneous metastases - A non-randomised phase II multicentre clinical trial.
Vissing M; Pervan M; Pløen J; Schnefeldt M; Rafaelsen SR; Jensen LH; Rody A; Gehl J
Eur J Surg Oncol; 2023 Sep; 49(9):106925. PubMed ID: 37268521
[TBL] [Abstract] [Full Text] [Related]
[Next]
